Long-Term, Low-Intensity Warfarin Therapy for the Prevention of Recurrent Venous ThromboembolismPaul M. Ridker, Robert J. Glynn, Mary Cushman et al.|New England Journal of Medicine|2003Cited by 809
Impact of Regulatory Guidance on Evaluating Cardiovascular Risk of New Glucose-Lowering Therapies to Treat Type 2 Diabetes MellitusAbhinav Sharma, Christopher B. Granger, Neha J. Pagidipati et al.|Circulation|2020Cited by 108
Optimising clinical trials in acute myocardial infarction complicated by cardiogenic shock: a statement from the 2020 Critical Care Clinical Trialists WorkshopMattia Arrigo, Alexandre Mebazaa, Susanna Price et al.|The Lancet Respiratory Medicine|2021Cited by 52